RE:RE:RE:RE:RE:I am getting the impressionI said it before I will say it again, and I know it's not a popular tune here, but one reason for the SP to go higher is because the financial risk of the company is much lower now with the last financing. Somebody can invest in Thera knowing they will be able to do what they need to do to hopefully create real value. We now know that they have enough cash for at least the next two years. Also, a 20% higher SP does not necessarilly means that a financing deal can be done at a 20% higher price. You still need to agree on the price and conditions. We saw that the first time they went to the NASDAQ. If I remember well, a deal went bad because buyers wanted a lower price and the company said no. It ended up being a very bad decision by Thera. The company almost went bankrupt after that.
ANALIAS00 wrote: We cant expect big news short term because TH would look bad for having signed such a deal recently. So if SP increase to 5$ (can) by any miracle in the next 2 weeks for example, that would meen investors has move confident than TH itself ? Dont you think Fred that this situation would look bizarre ? If Paul provide sooooo much confidence in TH future tomorrow, dont you think he should have signed a better deal than what he did recently ? That is why some like me are still trying to understand the all story about the last financing. That is why we must be caution about Nash and sales and also oncology. I repeat, I agree, TH in comparaison to many others, TH is clearly undervaluated but TH themself obviously seem not to agree based on the deal they made.
ANALIAS00 wrote: Skeptic ? I cant be skeptical at this point ? I do believe SP should be higher if I compare with Cie in a similar situation as TH. Until phase I results are out, it is not a question of being skeptical. We can only hope and TH do the same. Of course they have more reasons than me to think It will work. But that wont be the first Cie to see their phase I failing. So Who am I to say that pre clinical testing results will be 100% the same in phase I ? Nobody knows. We are hoping. We are speculating. Nothing to do with being skeptical. I fully agree that if phase I works well on human, SP will reflect that proportionnaly to the results. I am positive at that. No skeptical at all. I sure am skeptical about Muslix statement earlier. That I am. You and him and me can only hope. Hope that until phase I results comes out, few things happen:
- TH can be valuated as other similar cie by the market
- Trogarzo and Egrifta sales increase
- TH provide good news on NASH Phase III progress
- New institutions and/or analysts come into play
IF and Only IF everything goes as hopped and planned (phase I positive results, increase in sales, nash phase iii on going,etc) in the next year, I can believe at a SP of 14$. But I am skeptical that it will be at 20$ or more. That you can say I am skeptical. I try to be realistic based on fact. It is not a fact that everything will ended the way you want.
FredTheVoice wrote: Always Analia the skeptic.......
Double ?
With ONCOLOGY and NASH ?
You mean rapidly, like in fast track.......double, and double again....
I know you dont believe in 20$C....
But before 14$C, you aint got a profit here, and it could happen very fast.....
Lets see.....
FTV.